Horizon Kinetics’s Ionis Pharmaceuticals IONS Stock Holding History

Horizon Kinetics’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$660K	Hold	12,200	–	–	0.02%	211
2018 Q3	$629K	Sell	12,200 -5,000	-29%	-$235K	0.02%	243
2018 Q2	$716K	Hold	17,200	–	–	0.02%	220
2018 Q1	$758K	Hold	17,200	–	–	0.02%	214
2017 Q4	$865K	Sell	17,200 -200	-1%	-$11K	0.03%	202
2017 Q3	$882K	Buy	17,400 +200	+1%	+$10.5K	0.03%	201
2017 Q2	$875K	Hold	17,200	–	–	0.03%	207
2017 Q1	$691K	Hold	17,200	–	–	0.02%	240
2016 Q4	$823K	Hold	17,200	–	–	0.03%	219
2016 Q3	$630K	Hold	17,200	–	–	0.02%	259
2016 Q2	$401K	Buy	17,200 +200	+1%	+$6.45K	0.01%	430
2016 Q1	$688K	Hold	17,000	–	–	0.02%	259
2015 Q4	$1.05M	Hold	17,000	–	–	0.02%	189
2015 Q3	$687K	Hold	17,000	–	–	0.01%	308
2015 Q2	$978K	Hold	17,000	–	–	0.01%	238
2015 Q1	$1.08M	Hold	17,000	–	–	0.01%	226
2014 Q4	$1.05M	Hold	17,000	–	–	0.01%	231
2014 Q3	$660K	Hold	17,000	–	–	0.01%	385
2014 Q2	$586K	Hold	17,000	–	–	0.01%	407
2014 Q1	$735K	Hold	17,000	–	–	0.01%	385
2013 Q4	$677K	Hold	17,000	–	–	0.01%	289
2013 Q3	$638K	Hold	17,000	–	–	0.01%	289
2013 Q2	$457K	Buy	+17,000	New	+$362K	0.01%	330

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Horizon Kinetics's IONS Position: Q4 2018 in Review

Horizon Kinetics held its Ionis Pharmaceuticals (IONS) position steady in Q4 2018 at 12,200 shares worth $660K. The position accounts for 0.02% of the portfolio, ranked #211.

Horizon Kinetics first reported a position in IONS in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.08M in Q1 2015. 330 funds tracked by Wall St. Rank hold IONS as of Q4 2018.

Horizon Kinetics held 12,200 shares of Ionis Pharmaceuticals worth $660K as of Q4 2018.
Horizon Kinetics left its Ionis Pharmaceuticals share count unchanged in Q4 2018.
Ionis Pharmaceuticals made up 0.02% of Horizon Kinetics's portfolio in Q4 2018, its #211 holding.
Horizon Kinetics first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
Horizon Kinetics's Ionis Pharmaceuticals position peaked at $1.08M in Q1 2015.
330 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.